Ciliary Neurotrophic Factor Acts on Distinctive Hypothalamic Arcuate Neurons and Promotes Leptin Entry Into and Action on the Mouse Hypothalamus.
AgRP neurons
NPY neurons
STAT3
arcuate nucleus
leptin resistance
median eminence
obesity
tanycytes
Journal
Frontiers in cellular neuroscience
ISSN: 1662-5102
Titre abrégé: Front Cell Neurosci
Pays: Switzerland
ID NLM: 101477935
Informations de publication
Date de publication:
2020
2020
Historique:
received:
13
03
2020
accepted:
24
04
2020
entrez:
13
6
2020
pubmed:
13
6
2020
medline:
13
6
2020
Statut:
epublish
Résumé
In humans and experimental animals, the administration of ciliary neurotrophic factor (CNTF) reduces food intake and body weight. To gain further insights into the mechanism(s) underlying its satiety effect, we: (i) evaluated the CNTF-dependent activation of the Janus kinase 2 (JAK2) and signal transducer and activator of transcription 3 (STAT3) pathway in mouse models where neuropeptide Y (NPY) and pro-opiomelanocortin (POMC) neurons can be identified by green fluorescent protein (GFP); and (ii) assessed whether CNTF promotes leptin signaling in hypothalamic feeding centers. Immunohistochemical experiments enabled us to establish that intraperitoneal injection of mouse recombinant CNTF activated the JAK2-STAT3 pathway in a substantial proportion of arcuate nucleus (ARC) NPY neurons (18.68% ± 0.60 in 24-h fasted mice and 25.50% ± 1.17 in fed mice) but exerted a limited effect on POMC neurons (4.15% ± 0.33 in 24-h fasted mice and 2.84% ± 0.45 in fed mice). CNTF-responsive NPY neurons resided in the ventromedial ARC, facing the median eminence (ME), and were surrounded by albumin immunoreactivity, suggesting that they are located outside the blood-brain barrier (BBB). In both normally fed and high-fat diet (HFD) obese animals, CNTF activated extracellular signal-regulated kinase signaling in ME β1- and β2-tanycytes, an effect that has been linked to the promotion of leptin entry into the brain. Accordingly, compared to the animals treated with leptin, mice treated with leptin/CNTF showed: (i) a significantly greater leptin content in hypothalamic protein extracts; (ii) a significant increase in phospho-STAT3 (P-STAT3)-positive neurons in the ARC and the ventromedial hypothalamic nucleus of normally fed mice; and (iii) a significantly increased number of P-STAT3-positive neurons in the ARC and dorsomedial hypothalamic nucleus of HFD obese mice. Collectively, these data suggest that exogenously administered CNTF reduces food intake by exerting a leptin-like action on distinctive NPY ARC neurons and by promoting leptin signaling in hypothalamic feeding centers.
Identifiants
pubmed: 32528252
doi: 10.3389/fncel.2020.00140
pmc: PMC7253709
doi:
Types de publication
Journal Article
Langues
eng
Pagination
140Informations de copyright
Copyright © 2020 Venema, Severi, Perugini, Di Mercurio, Mainardi, Maffei, Cinti and Giordano.
Références
Front Neurosci. 2013 Dec 27;7:263
pubmed: 24409114
J Neurosci. 2001 Apr 1;21(7):2413-24
pubmed: 11264315
Endocrinology. 2007 Nov;148(11):5414-23
pubmed: 17690165
Annu Rev Psychol. 2000;51:255-77
pubmed: 10751972
Dis Model Mech. 2017 Jun 1;10(6):679-689
pubmed: 28592656
JAMA. 2003 Apr 9;289(14):1826-32
pubmed: 12684362
Science. 2005 Oct 28;310(5748):679-83
pubmed: 16254185
J Anat. 2012 Jun;220(6):622-31
pubmed: 22458546
J Clin Invest. 2000 Jun;105(12):1827-32
pubmed: 10862798
Neurology. 1996 May;46(5):1244-9
pubmed: 8628460
Proc Natl Acad Sci U S A. 2006 Jul 11;103(28):10707-12
pubmed: 16818888
Nat Genet. 1999 Jan;21(1):119-22
pubmed: 9916804
Mol Metab. 2018 Feb;8:13-22
pubmed: 29254602
Endocrinology. 2003 May;144(5):2121-31
pubmed: 12697721
Science. 1979 Jun 29;204(4400):1434-6
pubmed: 451576
Int J Obes (Lond). 2019 Jun;43(6):1305-1318
pubmed: 30283080
Diabetes. 2004 Apr;53(4):911-20
pubmed: 15047605
Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4652-7
pubmed: 11259650
Neurochem Int. 2019 Sep;128:135-142
pubmed: 31002894
Cell Metab. 2013 Apr 2;17(4):607-17
pubmed: 23562080
Peptides. 1996;17(2):305-11
pubmed: 8801538
Nat Med. 1995 Nov;1(11):1155-61
pubmed: 7584987
Nature. 2003 Feb 20;421(6925):856-9
pubmed: 12594516
J Comp Neurol. 2010 Apr 1;518(7):943-62
pubmed: 20127760
Exp Brain Res. 2000 May;132(1):10-26
pubmed: 10836632
J Neuroendocrinol. 2003 Jul;15(7):649-60
pubmed: 12787049
Neuroendocrinology. 2016;103(3-4):223-9
pubmed: 26088805
EMBO J. 2018 Nov 2;37(21):
pubmed: 30209240
Brain Res. 2008 Jun 18;1215:105-15
pubmed: 18485333
Front Neurosci. 2019 Mar 19;13:240
pubmed: 30941008
Nature. 2019 Oct;574(7776):63-68
pubmed: 31554967
J Neurobiol. 1994 Nov;25(11):1436-53
pubmed: 7852996
Nature. 2000 Apr 6;404(6778):661-71
pubmed: 10766253
Cell. 2017 Feb 23;168(5):758-774
pubmed: 28235194
Nat Neurosci. 2017 Mar;20(3):484-496
pubmed: 28166221
Cell Tissue Res. 1983;228(3):597-640
pubmed: 6831534
Peptides. 1999 Nov;20(11):1341-5
pubmed: 10612449
Nature. 1994 Dec 1;372(6505):425-32
pubmed: 7984236
Cell Metab. 2014 Feb 4;19(2):293-301
pubmed: 24506870
J Neuroendocrinol. 2004 Feb;16(2):105-12
pubmed: 14763996
Mol Endocrinol. 2008 Mar;22(3):751-9
pubmed: 18096691
Ann N Y Acad Sci. 1995 Jul 21;762:407-9
pubmed: 7668543
Cell Tissue Res. 2012 Aug;349(2):589-603
pubmed: 22584508
Brain Res. 2015 Oct 5;1622:217-29
pubmed: 26133794
Endocrinology. 2012 Jun;153(6):2647-54
pubmed: 22518062
World J Biol Psychiatry. 2019 Nov;20(9):742-746
pubmed: 29869578
J Comp Neurol. 2013 Oct 15;521(15):3389-405
pubmed: 23649873
Endocrinology. 1998 Aug;139(8):3485-91
pubmed: 9681499
Nat Med. 2013 Dec;19(12):1584-96
pubmed: 24309662
Eur J Neurol. 2008 Apr;15(4):355-9
pubmed: 18353124
Cell Metab. 2015 Dec 1;22(6):962-70
pubmed: 26603190
J Clin Invest. 2016 Dec 1;126(12):4727-4734
pubmed: 27906690
Cell Rep. 2017 Jun 13;19(11):2257-2271
pubmed: 28614713
Nat Neurosci. 2012 Mar 25;15(5):700-2
pubmed: 22446882
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):E697-706
pubmed: 23386726
Ann Neurol. 1996 Feb;39(2):256-60
pubmed: 8967757
Front Neurosci. 2015 Oct 29;9:385
pubmed: 26578854
Front Neurosci. 2016 Jun 27;10:289
pubmed: 27445662